choline alphoscerate
Small moleculeexperimental
L-α-Glycerophosphorylcholine is a natural choline compound found in the brain. It is also a parasympathomimetic acetylcholine precursor which has been investigated for its potential for the treatment of Alzheimer's disease and other dementias. — Wikipedia
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
1
Earliest trial started May 2, 2017 (NCT03228498)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Mechanism of action
- cholineSupplementation
choline supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaGlycerophosphorylcholine ↗
- WikipediaAlpha-GPC ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05257902 | N/A | Mar 31, 2022 | Sungkyunkwan University |
| NCT03441516 | Phase 4 | Mar 5, 2018 | Yuhan Pharmaceutical Company |
| NCT03228498 | Phase 2 | May 2, 2017 | MDM S.p.A., University of Florence |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MDM S.p.A. | For profit | 1 | 0 | 1 | 2017 |
| Sungkyunkwan University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| University of Florence | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Yuhan Pharmaceutical Company | For profit | 1 | 1 | 1 | 2018 |
4 organizations
Page 1 / 1